12 Weeks of Resistance Band Exercise Impacts on Metabolic Syndrome Progression in Postmenopausal Women

Overview

The purpose of this study was to examine the impacts of a 12-week resistance band exercise program on insulin resistance, blood lipid profiles, body composition, and blood pressure in postmenopausal women with obesity.

Thirty-six postmenopausal women participated in this study. Participants were randomly allocated into the resistance band training group (EX, n = 18) or the control group (CON, n = 18). The EX group performed a resistance band exercise training program 60 minutes per day, 3 times per week, for 12 weeks. The CON group did not participate in any exercise, dietary, or behavioral intervention. Blood glucose, insulin, homeostatic model of insulin resistance (HOMA-IR), blood lipids, blood pressure, and body composition were measured before and after 12 weeks of EX or CON.

Full Title of Study: “Impacts of 12 Weeks of Resistance Band Exercise Training on Insulin Resistance, Blood Lipids, Body Composition, and Blood Pressure in Postmenopausal Women With Obesity”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Health Services Research
    • Masking: None (Open Label)
  • Study Primary Completion Date: August 1, 2018

Interventions

  • Other: No exercise intervention group
    • no exercise intervention
  • Behavioral: Resistance band exercise intervention group
    • Resistance band exercise training intervention (12 weeks, 3x per week, for 60 minutes per day)

Arms, Groups and Cohorts

  • Sham Comparator: Control group
    • No exercise intervention
  • Experimental: Exercise intervention group
    • Exercise intervention group (resistance band exercise training for 12 weeks, 3x per week, for 60 minutes per day).

Clinical Trial Outcome Measures

Primary Measures

  • Glucose
    • Time Frame: 12 weeks
    • Blood glucose was measured before and after 12 weeks.
  • Insulin
    • Time Frame: 12 weeks
    • Blood insulin was measured before and after 12 weeks.
  • Percentage of Body Fat
    • Time Frame: 12 weeks
    • Body fat percentage was measured before and after 12 weeks.
  • Waist circumference
    • Time Frame: 12 weeks
    • Waist circumference was measured before and after 12 weeks.

Secondary Measures

  • Systolic blood pressure
    • Time Frame: 12 weeks
    • Systolic blood pressure was measured before and after 12 weeks.
  • Diastolic blood pressure
    • Time Frame: 12 weeks
    • Diastolic blood pressure was measured before and after 12 weeks.

Participating in This Clinical Trial

Inclusion Criteria

  • postmenopausal (cessation of menses for at least 12 consecutive months)
  • abdominal obesity (waist > 80 cm)

Exclusion Criteria

  • current smoker (smoking within 6 months of participation)
  • cardiovascular disease
  • renal disease
  • pulmonary disease
  • thyroid disease

Gender Eligibility: Female

Female, postmenopausal

Minimum Age: N/A

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Nebraska, Omaha
  • Provider of Information About this Clinical Study
    • Principal Investigator: Song-Young Park, Principal Investigator – University of Nebraska, Omaha

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.